Cala Health kIQ
Cala Health kIQ
Cala Health kIQ
Cala Health kIQ
Cala Health kIQ
Cala Health kIQ
Cala Health kIQ
Cala Health kIQ
Cala Health kIQ
Cala Health kIQ
Cala Health kIQ
Cala Health kIQ
Cala Health kIQ
Cala Health kIQ
2024

Share:

Cala Health kIQ

On-demand FDA approved therapy for tremor relief

Millions of people live with essential tremor or Parkinson’s disease. The effects of these tremors are debilitating, interfering with quality of life, and the ability to undertake everyday activities that many of us take for granted. Treatment options for these conditions have historically been medications or even surgery. The Cala kIQ System is a sleek, empowering, accessibly-designed wearable that delivers powerful, non-pharmacologic, and non-invasive TAPS (Transcutaneous Afferent Patterned Stimulation) therapy on demand, to radically reduce tremors and improve daily living. It’s the only FDA-approved device of its kind.

Client / Manufacturer

Cala Health

San Mateo, US
Design

PA Consulting design team

San Francisco, US
Date of Launch
2023
Development Time
up to 24 Month
Target Regions
North America
Target Groups
Consumers / Users

RELATED PROJECTS